SERNIVO

Peak

betamethasone dipropionate

NDATOPICALSPRAY
Approved
Feb 2016
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1

Clinical Trials (1)

NCT00437619Phase 4Completed

A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Started Feb 2007
200 enrolled
Psoriasis

Loss of Exclusivity

LOE Date
Aug 31, 2030
54 months away
Patent Expiry
Aug 31, 2030

Patent Records (5)

Patent #ExpiryTypeUse Code
10179137
Aug 31, 2030
Product
U-1858
9364485
Aug 31, 2030
Product
U-1858
9433630
Aug 31, 2030
Product
U-1858
9439911
Aug 31, 2030
Product
U-1858
9655907
Aug 31, 2030
Product
U-1858